Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood acute lymphoblastic leukemia.

Rubnitz JE, Campbell P, Zhou Y, Sandlund JT, Jeha S, Ribeiro RC, Inaba H, Bhojwani D, Relling MV, Howard SC, Campana D, Pui CH.

Cancer. 2013 Jun 1;119(11):2061-6. doi: 10.1002/cncr.28026. Epub 2013 Mar 1.

2.

Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia.

Rabin KR, Gramatges MM, Borowitz MJ, Palla SL, Shi X, Margolin JF, Zweidler-McKay PA.

Pediatr Blood Cancer. 2012 Sep;59(3):468-74. doi: 10.1002/pbc.23395. Epub 2011 Nov 18.

3.

Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.

Sun D, Elson P, Liedtke M, Medeiros BC, Earl M, Alizadeh A, Bates J, Sekeres MA, Coutre S, Kalaycio M, Sobecks R, Copelan E, Advani AS.

Am J Hematol. 2012 Oct;87(10):957-60. doi: 10.1002/ajh.23279. Epub 2012 Jun 22.

4.

The ratio of absolute lymphocyte count at interim of therapy to absolute lymphocyte count at diagnosis predicts survival in childhood B-lineage acute lymphoblastic leukemia.

Cheng Y, Luo Z, Yang S, Jia M, Zhao H, Xu W, Tang Y.

Leuk Res. 2015 Feb;39(2):144-50. doi: 10.1016/j.leukres.2014.11.013. Epub 2014 Dec 9.

PMID:
25542697
5.

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

Borowitz MJ, Devidas M, Hunger SP, Bowman WP, Carroll AJ, Carroll WL, Linda S, Martin PL, Pullen DJ, Viswanatha D, Willman CL, Winick N, Camitta BM; Children's Oncology Group.

Blood. 2008 Jun 15;111(12):5477-85. doi: 10.1182/blood-2008-01-132837. Epub 2008 Apr 3.

6.

Absolute Lymphocyte Count Recovery Independently Predicts Outcome in Childhood Acute Lymphoblastic Leukemia: Experience From a Tertiary Care Cancer Center of a Developing Country.

Gupta A, Kapoor G, Jain S, Bajpai R.

J Pediatr Hematol Oncol. 2015 Apr;37(3):e143-9. doi: 10.1097/MPH.0000000000000249.

PMID:
26201035
7.

[Absolute lymphocyte count as a prognostic factor in children with acute lymphoblastic leukemia].

Anoceto Martínez A, González Otero A, Guerchicoff de Svarch E, Arencibia Nuñez A, Jaime JC, Dorticos E, Sarduy S, González L.

An Pediatr (Barc). 2012 Jan;76(1):10.e1-6. doi: 10.1016/j.anpedi.2011.07.001. Epub 2011 Sep 8. Spanish.

8.

Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies.

De Angulo G, Yuen C, Palla SL, Anderson PM, Zweidler-McKay PA.

Cancer. 2008 Jan 15;112(2):407-15.

9.

[Clinical significance of dynamic monitoring the minimal residual disease in childhood B-lineage acute lymphoblastic leukemia by multiparameter flow cytometry].

Guo DD, Zhao WL, Zhang YL, Pang L, Che L, He HL, Chai YH, Ji ZH, Ji XQ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Dec;20(6):1346-51. Chinese.

PMID:
23257430
10.

[Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance].

Xu XJ, Tang YM, Song H, Shi SW, Yang SL, Shen HQ, Wei J, Xu WQ, Pan BH, Zhao FY.

Zhonghua Er Ke Za Zhi. 2010 Mar;48(3):180-4. Chinese.

PMID:
20426951
11.

Absolute lymphocyte count is associated with minimal residual disease level in childhood B-cell precursor acute lymphoblastic leukemia.

Shen HQ, Feng JH, Tang YM, Song H, Yang SL, Shi SW, Xu WQ.

Leuk Res. 2013 Jun;37(6):671-4. doi: 10.1016/j.leukres.2013.02.002. Epub 2013 Feb 28.

PMID:
23453285
12.

Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia.

Wasserman R, Galili N, Ito Y, Silber JH, Reichard BA, Shane S, Womer RB, Lange B, Rovera G.

J Clin Oncol. 1992 Dec;10(12):1879-88.

PMID:
1453203
13.

Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia.

Hirase S, Hasegawa D, Takahashi H, Moriwaki K, Saito A, Kozaki A, Ishida T, Yanai T, Kawasaki K, Yamamoto N, Kubokawa I, Mori T, Hayakawa A, Nishimura N, Nishio H, Iijima K, Kosaka Y.

Int J Hematol. 2015 Nov;102(5):594-601. doi: 10.1007/s12185-015-1875-0. Epub 2015 Oct 6.

PMID:
26440971
14.

[Prognostic value of both detection of lymphoblasts in the period of early treatment and minimal residual disease in childhood acute lymphoblastic leukemia].

Tie LJ, Gu LJ, Song DL, Jiang LM, Xue HL, Tang JY, Dong L, Pan C, Chen J, Ye H, Wang YP, Chen J.

Zhonghua Xue Ye Xue Za Zhi. 2005 Jan;26(1):6-9. Chinese.

PMID:
15946500
15.

Outcome and prognostic factors of acute lymphoblastic leukemia in children at the National Cancer Institute, Egypt.

Hussein H, Sidhom I, Naga SA, Amin M, Ebied E, Khairy A, Kamel A, El-Sharkawy N.

J Pediatr Hematol Oncol. 2004 Aug;26(8):507-14.

PMID:
15284589
16.

Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group.

Heerema NA, Carroll AJ, Devidas M, Loh ML, Borowitz MJ, Gastier-Foster JM, Larsen EC, Mattano LA Jr, Maloney KW, Willman CL, Wood BL, Winick NJ, Carroll WL, Hunger SP, Raetz EA.

J Clin Oncol. 2013 Sep 20;31(27):3397-402. doi: 10.1200/JCO.2013.49.1308. Epub 2013 Aug 12.

17.

Implication of early lymphocyte recovery after allogeneic hematopoietic stem cell transplantation in children with leukemia.

Han DK, Baek HJ, Kim SY, Hwang TJ, Kook H.

Yonsei Med J. 2013 Jan 1;54(1):62-70. doi: 10.3349/ymj.2013.54.1.62.

18.

A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse.

Jacquy C, Delepaut B, Van Daele S, Vaerman JL, Zenebergh A, Brichard B, Vermylen C, Cornu G, Martiat P.

Br J Haematol. 1997 Jul;98(1):140-6.

PMID:
9233577
19.

[Prognostic value of early treatment response in children with acute lymphoblastic leukemia: a single institution experience in Shanghai, China].

Tie LJ, Gu LJ, Song DL, Jiang LM, Xue HL, Tang JY, Dong L, Pan C, Chen J, Ye H, Chen J.

Zhongguo Dang Dai Er Ke Za Zhi. 2009 Jan;11(1):5-9.

PMID:
19149913
Items per page

Supplemental Content

Write to the Help Desk